Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients; pharmaceutical services on biomarker detection and companion diagnostics developing; and NGS-based cancer early detection. The company provides OncoScreen, a cancer mutation profiling tissue kit; OncoCompass, a liquid biopsy test for cancer patients; brPROPHET, a residual disease detection and monitoring tool; OverC, in vitro diagnostic device for the detection of DNA methylation marker; etc.